Beauty Without Rules Became Public Harm -By Fransiscus Nanga Roka

It was an inevitable scandal. By 2025, the aesthetics industry around the world had ceased to be the glimmering consumer marketplace that regulators were happy to let it be and had started to look like what they had long tolerated: a public health minefield dressed up as self-care.

For the UK this reckoning was long overdue, it had been brought to a head after extensive investigations revealed two horrifying truths. First, confirmed cases of iatrogenic botulism were caused by illegal or counterfeit Botoxy. Second, though, high powered teeth whitening solutions with leave the kinds of hydrogen peroxide existing commercially that are proposed by products to procreate teeth in front astonishing flesh burns and dental loss within an excess elevation. This was not a tale of hubris run amok. A tale of lax oversight, profit-driven neglect and a licensing void providing an open invitation to criminality.

On Fake injectables, toxic skin whitening products and unsafe non surgical cosmetic procedures. Consumers, unscrupulous beauty operatives, negligent prescribers and the suppliers and regulators tasked with limiting damage. Around mid to late 2025, when investigations and enforcement intensified. Predominantly within the UK space, but having repercussions across to other regions e.g. being monitored from the US as well. Well, simply because aesthetic medicine is something that didn’t lag behind in evolution with the law, enforcement and ethical control. By exploiting prescription loopholes, issuing fake training certificates, smuggling drugs in from overseas markets, prescribing remotely, as well as salons moonlighting and posing as clinics.

The most damning fact is not that bad actors existed. Every industry has them. The real indictment is that the system allowed them to thrive. Culturally, Botox has been marketed for far too long as an innocuous beauty treatment when it ought to be treated legally and operationally as a prescription-only medicine. Dangerous whitening chemicals were spread like a viral video through salons, social media and backdoor deals as though causing damage to teeth was just an accepted hazard of commerce.

The investigation into botulism cases and the subsequent action taken by the MHRA demonstrate that governments are finally moving away from the childlike fantasy that the market will sort itself out, something i have written about before. It will not. When consumers have no way to verify sterility, authenticity, dosage, licensing or supply-chain integrity the markets do not self-correct. Fraud becomes a business model in that vacuum.

And this is why the UK’s proposed national licensing scheme for non-surgical cosmetic procedures is so significant, and not just to Britain. It is not bureaucratic overreach. It is overdue containment. There is nothing anti-business about restricting high-risk procedures to appropriate certified personnel, stopping non-professionals from carrying out independent injections and ensuring that the prescription of face-to-face consultations take place before treatment, providing common running conditions for clinics and tightening up on indemnity insurance. They are the bare minimum requirements for civilized practice in healthcare-related sectors.

This is a clear lesson worldwide: the age of caveat emptor in aesthetics is gone. It should be. If a procedure is capable of paralysis, nerve damage, tissue burning, or localized toxin spreads the provider is no longer in the business of selling beauty. They are conducting an volume health intervention.

The response can no longer be a superficial one. It has to be structural, punitive and global. National licence systems are the first step on the road to protection, and need to be designed around risk-tier categories that distinguish between low-risk beauty services and those that pose risks of poisoning, burning, paralysis or permanent disfigurement. A facial is a non-injectable. When the concentrations of chemicals in teeth whitening come close to industrial danger, it is not safe. Regulators have to stop pretending that these procedures exist in the same legal universe.

Which is why anything to be injected or high strength bleaching agents has to come under stringent medical and dental supervision. Any substance that can change muscle use, injure oral soft tissue or systemic disease will never be a retail product. The law necessarily needs to acknowledge that which the market has long hidden: that what are typically sold as aesthetic services are actually medical-risk procedures marketed in the language of beauty.

The biggest loophole is frequently not the needle but the prescription. Governments ought to ban remote prescribing abuses, and audit prescriptions far more aggressively, in particular where consultations are faked or through delegation or via messaging apps. A prescription written without ever physically assessing a patient is not convenience; it is institutionalized recklessness.

But enforcement cannot be limited by borders; it needs global cooperation. There is a rapid flow of counterfeit toxins, incorrectly labeled gels and illegal devices through international supply chains that local regulators cannot keep up with. States require partnerships for cross-border enforcement, sharing of customs intelligence, and digital marketplace monitoring to interdict illegal goods before they hit clinics, salons or consumers.

One must also clean up professional entry. True legitimacy should only be received through accredited training, and each competent practitioner with any suitable training must go into a public practitioner registry for consumers to simply cross-check credentials. Use insurance as a lever for compliance: if limits in concentration are not adhered to, if only unlicensed products are used or unqualified personnel employed, the coverage should collapse from itself. That would render illegal practice not just unlawful, but commercially unviable.

Governments should also not just speak to providers but warn the public. Consumer campaigns need to convey a simple narrative: that cosmetic brand marketing has the power to mask clinical risk. The needle may look beautiful in Duchess. Actually, the issue will appear to be emergency care.

Don’t get me wrong: this crackdown isn’t the death knell of the aesthetics industry. This is their last chance for legitimacy. If governments manage to fail again, the next scandal will not only leave scars on faces and mouths. It will leave an indelible scar on the trust of the public.

Fransiscus Nanga Roka

Faculty of Law University 17 August 1945 Surabaya and Managing Partner Law Firm Victorious Indonesia